Company overview

Evogene helps partners find and refine molecules for potential medicines and agricultural chemicals. After narrowing its business, it now focuses on ChemPass AI, which designs and screens molecules computationally; laboratory testing checks their biological activity. Partners typically lead experimental development and pay for research, licensing rights and progress toward agreed milestones. Outside castor-seed sales, revenue comes mainly from subsidiary AgPlenus’s weed-control collaboration with Bayer and on-farm cultivation services.

The business is still largely in development. Evogene earns no royalties, and its candidates have not reached commercial sale except for Casterra’s castor varieties. Turning discoveries into royalty-paying products depends on partners continuing development, meeting milestones and obtaining required regulatory approvals.

Casterra provides a separate sales business: it sells proprietary castor seeds and cultivation solutions for industrial castor-oil production. Its customer ENI Kenya buys seeds for biofuel feedstock cultivation, but had placed no further orders by the annual report date after receiving earlier backlog deliveries. Casterra has shifted most of its efforts toward Brazil as its principal African customer reduced activity.